Capital One (COF)

Total Costs & Expenses

$62.44B

TTM · Period ending: · USD

COF logo

COF Total Costs & Expenses

Latest reported$62.44B
COF TTM Total Costs & Expenses ($0.00 → $62.44B)
High-resolution chart · PNG

COF total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Capital One Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
62,435,000,000
62,091,000,000
71,913,000,000
66,971,000,000
61,806,000,000
57,945,000,000
48,222,000,000
48,055,000,000
47,905,000,000
46,919,000,000
44,640,000,000
43,439,000,000
40,696,000,000
37,917,000,000
33,826,000,000
29,133,000,000
25,116,000,000
21,527,000,000
18,483,000,000
16,224,000,000
15,575,000,000
15,888,000,000
21,560,000,000
28,440,000,000
30,832,000,000
32,886,000,000
30,463,000,000
26,892,000,000
26,208,000,000
25,765,000,000
25,059,000,000
24,560,000,000
24,557,000,000
24,527,000,000
24,651,000,000
24,507,000,000
24,004,000,000
23,350,000,000
22,846,000,000
22,035,000,000
21,325,000,000
20,515,000,000
19,986,000,000
19,157,000,000
18,656,000,000
18,368,000,000
17,612,000,000
17,300,000,000
17,171,000,000
17,199,000,000
17,356,000,000
17,643,000,000
17,349,000,000
17,620,000,000
18,817,000,000
17,508,000,000
17,132,000,000
15,942,000,000
13,669,000,000
13,929,000,000
13,464,000,000
13,561,000,000
13,887,000,000
14,737,000,000
14,629,806,000
14,738,806,000
14,889,806,000
14,613,616,000
16,972,238,000
17,158,512,000
17,133,344,000
17,220,491,000
15,973,183,000
15,776,157,000
15,830,180,000
15,421,836,000
14,351,324,000
13,606,827,000
12,683,389,000
11,538,230,000
10,938,581,000
10,245,031,000
9,608,228,000
9,255,984,000
8,892,451,000
8,691,067,000
8,496,450,000
8,334,513,000
7,952,818,000
7,923,846,000
7,938,519,000
7,958,791,000
7,899,470,000
8,106,406,000
8,245,472,000
8,154,157,000
7,802,041,000
7,223,927,000
6,638,553,000
6,251,338,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.